To review measures used in recent randomised controlled trials (RCTs) evaluating stress urinary incontinence (SUI) treatments and to propose the most relevant outcome measure that should be included in future trials.
Introduction
The efficacy of the surgical and non-surgical options to treat stress urinary incontinence (SUI) has been examined extensively in clinical trials [1] [2] [3] . Different organisations including the European Association of Urology (EAU) [4, 5] , the AUA [6] , and the International Consultation on Incontinence (ICI) [7] recommend use of myriad outcomes under different domains to examine effectiveness of incontinence interventions. The EAU recommends reporting patient-reported symptoms, quality of life (QoL), objective outcomes, complications, and health-economic outcome [4, 5] . The AUA suggests using a standardised questionnaire, subjective outcomes, and objective outcomes [6] ; whilst the ICI recommends use of patient-reported and objective outcomes, as well as adverse events reporting [7] .
The absence of consensus on the most important outcome measure (primary outcome measure) and the plethora of outcome measures recommended have led to several problems. Accordingly, clinical trials investigating SUI treatments used a diverse range of outcome measures to quantify treatment effects [8, 9] . During the course of the clinical trial, inclusion of many measures is burdensome to both investigators and participants. Further, it is often unclear why these measures were selected. When the findings are published, clinicians find it arduous to interpret results from different studies [10] . This is further complicated when the outcome measures within the same study present conflicting findings. For example, a randomised controlled trial (RCT, n = 504) comparing active vs sham electroacupuncture in women with SUI, reported a significant difference in the primary outcome measure (amount of urine leakage as measured using the 1-h pad test) [11] . However, there were no significant differences in two secondary outcome measures, which were weekly mean number of urine pads used and the number of participants using urine pads [11] .
Under such circumstances, systematic reviews and metaanalyses become useful in assisting clinicians make informed decisions. However, researchers face a persistent problem; deciding which measures to pool from the studies to estimate the treatment effect size. Often only a handful of trials report similar measures that can be congregated in a meta-analysis [3, 12] , whilst other trials included in the systematic review that do not use similar measures are of no value to that particular outcome. If high-quality evidence cannot be synthesised from existing studies, researchers then need to conduct more RCTs. A vicious cycle is formed -inability to pool results in meta-analyses due to lack of RCTs with consistent measures, resulting in more RCTs needed but often still conducted with varying measures, which leads to difficulty in interpretations that reinforce the need to pool results in meta-analyses.
Use of critical outcomes is an important criterion for judging quality of evidence in a systematic review [13] . Despite a large number of trials included in the recent Cochrane reviews [1] [2] [3] , numerous sources of heterogeneity including the substantial diversity in outcomes have led to very low-tolow [1, 3] , or low-to-moderate [2] quality of evidence. Whilst we agree that multiple measures may be required to examine effects of interventions on different domains of interest [14] , we believe that unanimity in having an outcome measure considered most relevant will reduce the problems in pooling of data in meta-analyses. The aims of the present study were three-fold: (i) to identify outcome measures used in RCTs involving interventions for SUI published between 2015 and 2017, (ii) to assess the correlation between outcome measures based on data from our recent clinical trial [9] , and (iii) to propose the most relevant outcome measure that should be included in future clinical trials investigating treatments for SUI.
Materials and Methods

Part 1 Evaluation of Outcome Measures used in RCTs
A literature search was conducted in August 2017 using Medline, Embase and Cochrane Central Register of Controlled Trials. All RCTs for surgical and non-surgical interventions for SUI published between January 2015 and July 2017 were screened. This period was chosen to allow inclusion of the most recent articles and to include a sufficient number of trials to allow comparison. Studies were included if they (i) included women with SUI; (ii) were RCTs of surgical or non-surgical interventions; and (iii) the primary aim of the trial was to evaluate effectiveness or safety of the intervention. Studies were excluded if they were (i) primarily for patients with other types of lower urinary tract problems such as pelvic organ prolapse; (ii) studies in men or pregnant women; or (iii) secondary analysis using data from a study that had already been published. The type of intervention, definition of cure or improvement, number of primary or secondary measures, and type of measures used (objective or subjective) were recorded. Descriptive statistics were used to report the frequency of use of each measure.
Part 2 Correlation between Study Outcome Measures
The second part of the study used data from our RCT of pulsed magnetic stimulation [9] . Data collected at 12-months after treatment was used to assess correlation between the study outcome measures. The outcome measures used were: (i) objective measures including the 1-h pad test [15] , 3-day incontinence episode frequency (voiding diary), and pelvic floor muscle strength (perineometer); and (ii) subjective measures including the ICI Questionnaire for Urinary Incontinence-Short Form (ICIQ-UI SF) [16] , ICI Questionnaire-Lower Urinary Tract Symptoms Quality of Life (ICIQ-LUTSqol), and Patient Global Impression of Improvement (PGI-I) [17] . The Spearman's rank correlation coefficient was used measure the correlation between the study outcome measures. Statistical analysis was performed using the IBM Statistical Package for the Social Sciences (SPSS â ) for Windows, version 22.0 (SPSS Inc., IBM Corp., Armonk, NY, USA).
Results
Part 1 Evaluation of Outcome Measures used in RCTs
A total of 45 RCTs were included; 28 (62%) studies involved surgical interventions. The median (range) number of outcome measures used was 4 (1-8). Most (n = 37, 82%) used both objective and subjective outcome measures. Five (11%) studies used only subjective outcome measures and three (7%) used only objective outcome measures. In all, 31 (69%) studies specified the primary outcome; 20 studies used only one primary outcome, whilst 11 used more than one primary outcome. Of the 31 studies that specified the primary outcome, 12 (39%) studies used subjective outcome only, 10 (32%) studies objective outcome only, whilst nine (29%) studies used a composite of objective and subjective outcomes. Study characteristics, definition of cure/ improvement, primary outcomes, and types of subjective and objective outcome measures used for individual studies are presented in Tables S1, S2, S3. A total of 24 different validated questionnaires were administered in the 42 studies that used subjective outcome measure ( Table 1 ). The most frequently used validated questionnaire was the ICIQ-UI SF, followed by the PGI-I and the Incontinence Impact Questionnaire ( Table 1 ). The most frequently used objective outcome measure was the cough 806 © 2018 The Authors BJU International © 2018 BJU International stress test, followed by the pad test and incontinence episode frequency ( Table 2 ). The 1-h pad test was the most commonly used pad test.
About two-thirds (n = 31, 69%) of studies reported their definition of success (cure or improvement) but the definition of success varied greatly (Table S1 ). Similarly, there was marked heterogeneity in the selection of the primary outcome measure.
Part 2 Correlation between Study Outcome Measures
At the 1-year follow-up, data from 106 patients with SUI were available for analysis. The mean (SD) age of the patients was 52.2 (8.9) years. All outcome measures were significantly correlated with each other except for pelvic floor muscle function ( Table 3 ). The strongest correlation was between the ICIQ-UI SF and the 1-h pad test (r = 0.733, P < 0.001). Overall, the ICIQ-UI SF showed the highest correlation with all other outcome measures, with correlation coefficients between 0.587 and 0.733 (P < 0.001). Pelvic floor muscle function was poorly correlated with all outcome measures, with correlation coefficients ranging from 0.008 to 0.181 (P > 0.05).
Discussion
Evaluation of outcome measures used in RCTs published between 2015 and 2017 for treating women with SUI showed that the measures varied considerably. There was no unanimity as to whether an objective or a subjective measure was perceived as more important when choosing the primary outcome. The cough stress test and the ICIQ-UI SF were the most commonly used objective and subjective measures, respectively. In the correlation study, all measures were significantly correlated with each other except for pelvic floor muscle function. The ICIQ-UI SF had the highest correlation with all other measures.
The Core Outcome Measures in Effectiveness Trials (COMET) Initiative suggested use of 'core outcome sets', which should be measured and reported in order to improve the comparability of trials in Cochrane reviews [18] . The urology organisations [4, 6, 7] recommended different domains that should be used when assessing patients. However, it is evident from our present findings that merely recommending 'core outcome sets' or 'domains' is simply not good enough. Recent RCTs continued to have few defined outcomes that could be combined in meta-analyses to achieve robust conclusions.
Further, the Consolidated Standards of Reporting Trials (CONSORT) statement recommended using only one primary outcome in RCTs [19] ; however, 11 (35%) of the 31 studies that specified their primary outcomes in our present review used more than one outcome. Use of more than one outcome, coupled with the high variability in the choice of measure and definition of success, make it very challenging to interpret the results due to the multiplicity of analyses. Use of multiple primary outcomes also creates the opportunity for authors to pick and choose, and to highlight the primary outcome that shows that the treatment 'works', which may mislead readers.
The cough stress test and the pad test are the two most commonly used measure; however, we argue that they may not be the most appropriate objective measures for the following reasons. The cough stress test may be too difficult to standardise for use in RCTs. In a review by Carmel et al. [20] , there was different cough stress test standardisation in all the 56 studies that used the cough stress test as a measure of success for surgical interventions for SUI. Similarly, the pad test is difficult to standardise and has different variation such as the 20-min, 1-h or 24-h pad test. Whilst a testing protocol has been standardised by the ICI for the 1-h pad test [7] , there remain differences in the way the studies conduct the tests. A study which assessed the repeatability of the 1-h pad test in 56 incontinent women found significant differences between tests conducted 1 week apart; the difference in pad gain ranged from À44 to +66 g [21] . Only 4.5-8% of urologists performed pad tests routinely in their clinical practice [22] . The underutilisation of the pad test and its low reliability, reproducibility, and usefulness [21, 23, 24] make it a questionable indicator for change after SUI treatment.
The correlation of outcome measures was evaluated using data from a single study; our recent RCT evaluating the effectiveness of pulsed magnetic stimulation [9] . Ideally, the correlation of measures should be evaluated using data from multiple trials evaluating surgical and/or non-surgical interventions. This would help identify outcome measures that are not clinically relevant to patients and thus prevent redundancy. For example, our study showed that the pelvic floor muscle parameters measured using a perineometer were poorly correlated with all other measures. This means that changes in perineometer values were not reflective of patients' perception of improvement. The use of a perineometer in research and practice may be questionable. All the subjective measures used in multiple studies (Table 1 ) should also ideally be tested across each other. This would require data acquisition from many studies, and at this stage, we do not have the capacity to conduct a study of that scale. It could also be argued that pulsed magnetic stimulation may not represent a standard non-surgical treatment; however, whether or not patients have had treatment should not affect the correlation results. A study conducted in patients with SUI who did not receive any treatment similarly found a high correlation between the 1-h pad test and the ICIQ-UI SF [25] . We would anticipate that similar correlation results would be seen in studies that used data from patients who IEF, incontinence episode frequency; n, number of patients; r, Spearman's rank correlation coefficient.
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Based on our present findings, we propose several suggestions to standardise outcome measures and ease pooling of data in systematic reviews. Firstly, we suggest use of the ICIQ-UI SF, as the most relevant outcome measure in SUI trials, because the ICIQ-UI SF (i) is a patient-reported outcome (considered most important and relevant); (ii) is the recommended module (Grade A) by the ICI [7] ; (iii) is valid, reliable and responsive to change [16, 26] ; (iv) is the most frequently used outcome measure in our present review; and (v) is highly correlated with other measures used in our trial. However, it is important to note that use of ICIQ-UI SF as an outcome measure should not preclude inclusion of other subjective measures that address different elements of QoL surrounding SUI. The ICIQ-UI SF is a three-item questionnaire that measures severity of incontinence. Our previous study has shown that limitation in physical activity was considered the most bothersome component of QoL [27] . Thus, a QoL questionnaire should also be included if changes in QoL components, such as physical activity, are considered important. Secondly, when questionnaires are included, only those that have been given Grade A scores by most, if not all organisations should be used. Thirdly, researchers should clearly articulate their primary and secondary outcome measures, justify their inclusion, and ensure that the measures chosen are readily accessible and easily integrated into the existing scope of clinical practice.
Some limitations should be considered when interpreting our present findings. The correlation of outcome measures was only evaluated in a single RCT. We are not able to make recommendation on choice of primary outcome measure because the aim of some studies may not be to quantify subjective cure or improvement of SUI symptoms. This would be applicable to trials involving more complicated interventions; e.g. in trials involving patients with de novo SUI or undergoing surgical intervention for SUI and pelvic organ prolapse. As we only included published papers and papers in English, the type of measures used in the studies included in our present review may not be similar to those used in 'grey' literature, unpublished work or articles published in other languages.
In conclusion, review of recent RCTs showed that the cough stress test and the ICIQ-UI SF were the most commonly used objective and subjective measures but the choice of outcome measures varied considerably. There was no unanimity when choosing the primary outcome measure. The ICIQ-UI SF had the highest correlation with all measures; however, further studies evaluating correlation of measures in other patient cohorts are needed to corroborate our results. Based on these findings, we propose the use of the ICIQ-UI SF, as the most relevant outcome measure, in future trials evaluating effectiveness of SUI interventions. Use of standardised or similar outcome measures will generate results that can be easily compared and pooled, which will strengthen the conclusions made in systematic reviews.
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